Form D · Hedge Fund

Arrowpoint Life Science Fund, L.P.

Denver, CO · CIK 0001556383

Offering snapshot reported Aug 14, 2014 · SEC filing

Reported sold: $27M
Investors reported: 8
Minimum accepted: $1
First sale: Sep 4, 2012

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Aug 14, 2014	Amendment	$27,000,000	$0vs Aug 14, 2013	8	SEC filing
Aug 14, 2013	Amendment	$27,000,000	No comparison	8	SEC filing
Aug 16, 2012	Initial	Yet to sell	No comparison	0	SEC filing

Offering details

Securities: Pooled investment fund
Exemptions: 06b, 3C, 3C.1
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-182840

Source: Form D, filed Aug 14, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

ARROWPOINT LIFE SCIENCE FUND, LP

Investment adviser: ARROWMARK COLORADO HOLDINGS, LLC

Gross asset value: $43.4M
Beneficial owners: 24
ADV minimum commitment: $2M

Reported in Form ADV on Mar 31, 2014. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator ALPS FUND SERVICES, INC. DENVER, Colorado, United States Investor statements: Yes (provided to all investors) Related to adviser: No

Auditor ROTHSTEIN KASS DENVER, Colorado, United States

Custodian GOLDMAN, SACHS & CO. NEW YORK, New York, United States Related to adviser: No

Prime broker GOLDMAN, SACHS & CO. NEW YORK, New York, United States

Provider details

Annual audit: Yes
Prime brokers: Yes
Custodians: Yes
Administrator other than the adviser: Yes
External marketing: No

GOLDMAN, SACHS & CO.
SEC 8-129

GOLDMAN, SACHS & CO.
CRD 361 · SEC 8-129

Filing source

Form ADV 789328 · Mar 31, 2014 · Schedule D 7.B.(1), fund 805-9699039367

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
David Corkins	Executive, Promoter
Karen Reidy	Executive
Minyoung Sohn	Executive
Tony Yao	Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:

100 Fillmore Street, Suite 325
Denver, CO, 80206